Literature DB >> 8581425

Conformational changes of small molecules binding to proteins.

M C Nicklaus1, S Wang, J S Driscoll, G W Milne.   

Abstract

Flexible molecules change their conformation upon binding to a protein. This was shown by the analysis of small molecules whose structures have been determined by X-ray crystallography of both the pure compound and the compound bound to a protein. Thirty-three compounds present both in the Cambridge Structural Database and the Brookhaven Protein Data Bank were analyzed, and both were compared with the global energy minimum conformation calculated by the molecular mechanics program CHARMm. It was found that the conformation bound to the protein differs from that in the crystal structure and also from that of the global energy minimum, and the degree of deformation depends upon the number of freely rotatable bonds in the molecule. Analysis of the conformational energies of the flexible molecules showed that, for most of those compounds, both the crystal and the protein-bound conformations are energetically well above the global minimum, and, in many cases, not even in any local energy minimum. Semi-empirical calculations performed for a select number of structures, using both the AM1 and PM3 hamiltonians, confirmed these results. These findings are discussed as to their impact upon contemporary methods of drug design.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581425     DOI: 10.1016/0968-0896(95)00031-b

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  41 in total

1.  MCDOCK: a Monte Carlo simulation approach to the molecular docking problem.

Authors:  M Liu; S Wang
Journal:  J Comput Aided Mol Des       Date:  1999-09       Impact factor: 3.686

2.  SLATE: a method for the superposition of flexible ligands.

Authors:  J E Mills; I J de Esch; T D Perkins; P M Dean
Journal:  J Comput Aided Mol Des       Date:  2001-01       Impact factor: 3.686

3.  Can we separate active from inactive conformations?

Authors:  David J Diller; Kenneth M Merz
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

4.  Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modeling.

Authors:  Despina Laimou; Eliada Lazoura; Anastassios N Troganis; Minos-Timotheos Matsoukas; Spyros N Deraos; Maria Katsara; John Matsoukas; Vasso Apostolopoulos; Theodore V Tselios
Journal:  J Comput Aided Mol Des       Date:  2011-11-01       Impact factor: 3.686

5.  PDB ligand conformational energies calculated quantum-mechanically.

Authors:  Markus Sitzmann; Iwona E Weidlich; Igor V Filippov; Chenzhong Liao; Megan L Peach; Wolf-Dietrich Ihlenfeldt; Rajeshri G Karki; Yulia V Borodina; Raul E Cachau; Marc C Nicklaus
Journal:  J Chem Inf Model       Date:  2012-02-21       Impact factor: 4.956

6.  Hierarchical clustering analysis of flexible GBR 12909 dialkyl piperazine and piperidine analogs.

Authors:  Kathleen M Gilbert; Carol A Venanzi
Journal:  J Comput Aided Mol Des       Date:  2006-07-20       Impact factor: 3.686

7.  Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.

Authors:  Denzil Bernard; Andrew Coop; Alexander D MacKerell
Journal:  J Med Chem       Date:  2007-03-17       Impact factor: 7.446

8.  Assessment of conformational ensemble sizes necessary for specific resolutions of coverage of conformational space.

Authors:  Yulia V Borodina; Evan Bolton; Fabien Fontaine; Stephen H Bryant
Journal:  J Chem Inf Model       Date:  2007-06-15       Impact factor: 4.956

9.  Common pharmacophore identification using frequent clique detection algorithm.

Authors:  Yevgeniy Podolyan; George Karypis
Journal:  J Chem Inf Model       Date:  2009-01       Impact factor: 4.956

10.  Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Jun Tian; Andrei I Khlebnikov; Richard D Ye; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2008-05-05       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.